4.3 Review

Innate and Innate-Like Immune System in Hypertension and Vascular Injury

Journal

CURRENT HYPERTENSION REPORTS
Volume 21, Issue 1, Pages -

Publisher

SPRINGER
DOI: 10.1007/s11906-019-0907-1

Keywords

Blood pressure; Inflammation; T cells; Natural killer cells; Dendritic cells; Macrophages; Antigen-presenting cells; Cytokines

Funding

  1. Canadian Institutes of Health Research (CIHR) [102606, 123465]
  2. CIHR First Pilot Foundation [143348]
  3. Tier 1 Canada Research Chair (CRC) on Hypertension and Vascular Research, CRC Government of Canada/CIHR Program
  4. Canada Fund for Innovation
  5. Canadian Vascular Network

Ask authors/readers for more resources

Purpose of ReviewTo describe the important role played by innate and innate-like immunity in the pathophysiology of hypertension and vascular injury.Recent FindingsInnate immune cells, such as neutrophils, dendritic cells, myeloid-derived suppressor cells, and monocytes/macrophages and innate lymphoid cells such as natural killer cells and unconventional T lymphocytes like T cells contribute to hypertensive mechanisms by priming adaptive immune cells, leading to the triggering of vascular inflammation and blood pressure elevation or alternatively protecting against vascular injury. Specifically, monocyte/macrophages and T cells seem to play a crucial role in the initiation of hypertension via regulation of adaptive immunity.SummaryInnate and innate-like immunity play a leading role in the pathophysiology of hypertension. Recent advances in this field provide us clues for future therapeutic approaches.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available